James B Hawkins sold $265k of IRMD
director at IRADIMED CORP. 3,000 shares at an average of $88.24, traded Nov 20, 2025, filed Nov 21, 2025.
Score components
- +15RoleDirector
- +13Trade size$265k at market
- 0Share of holdings soldSold 8.9% of holdings
- +15Cluster3 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000898243-25-000018, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 20, 2025 | SOpen-market sale Common Stock | -28 | $88.29 | $2,472 | 33,517 | Nov 21, 2025 |
| Nov 20, 2025 | SOpen-market sale Common Stock | -100 | $88.28 | $8,828 | 33,417 | Nov 21, 2025 |
| Nov 20, 2025 | SOpen-market sale Common Stock | -100 | $88.26 | $8,826 | 33,317 | Nov 21, 2025 |
| Nov 20, 2025 | SOpen-market sale Common Stock | -772 | $88.20 | $68k | 32,545 | Nov 21, 2025 |
| Nov 20, 2025 | SOpen-market sale Common Stock | -1,000 | $88.50 | $89k | 31,545 | Nov 21, 2025 |
| Nov 20, 2025 | SOpen-market sale Common Stock | -1,000 | $88.00 | $88k | 30,545 | Nov 21, 2025 |
Related signals
Other insiders at IRADIMED CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | IRMDsell IRADIMED CORP | Monty K Allen director | $123k 1,419 shares | -7% | |
| 27Weak | IRADIMED CORP | Roger E. Susi CEO, PRESIDENT, CHAIRMAN | $753k 7,500 shares | -0% | |
| 27Weak | IRADIMED CORP | Roger E. Susi CEO, PRESIDENT, CHAIRMAN | $763k 7,500 shares | -0% | |
| 27Weak | IRADIMED CORP | Roger E. Susi CEO, PRESIDENT, CHAIRMAN | $750k 7,500 shares | -0% | |
| 26Weak | IRADIMED CORP | Roger E. Susi CEO, PRESIDENT, CHAIRMAN | $738k 7,500 shares | -0% | |
| 25Weak | IRMDsell IRADIMED CORP | Monty K Allen director | $100k 1,000 shares | -5% | |
| 23Weak | IRADIMED CORP | Roger E. Susi CEO, PRESIDENT, CHAIRMAN | $503k 5,000 shares | -0% | |
| 23Weak | IRADIMED CORP | Roger E. Susi CEO, PRESIDENT, CHAIRMAN | $509k 5,000 shares | -0% | |
| 23Weak | IRADIMED CORP | Roger E. Susi CEO, PRESIDENT, CHAIRMAN | $487k 5,000 shares | -0% | |
| 23Weak | IRADIMED CORP | Roger E. Susi CEO, PRESIDENT, CHAIRMAN | $488k 5,000 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.